LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Dr. Lal PathLabs rises with arm receiving nod to acquire Satya Pathology and Diagnostic Centre

Dr. Lal PathLabs rises with arm receiving nod to acquire Satya Pathology and Diagnostic Centre (13-Dec-2017)

Dr. Lal PathLabs is currently trading at Rs. 885.90, up by 7.35 points or 0.84% from its previous closing of Rs. 878.55 on the BSE.

The scrip opened at Rs. 904.00 and has touched a high and low of Rs. 904.00 and Rs. 882.30 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1134.50 on 10-Jan-2017 and a 52 week low of Rs. 717.65 on 24-Oct-2017.

Last one week high and low of the scrip stood at Rs. 904.00 and Rs. 870.00 respectively. The current market cap of the company is Rs. 7,382.00 crore.

The promoters holding in the company stood at 57.92%, while Institutions and Non-Institutions held 21.92% and 20.17% respectively.

Dr. Lal PathLabs' subsidiary -- Paliwal Diagnostics has received an approval to acquire a Proprietorship Concern. i.e. Satya Pathology and Diagnostic Centre (SPDC).  The Board of Directors of the company's Subsidiary at their meeting held on December 12, 2017, approved the same.

The company's subsidiary has decided to acquire 100% stake in SPDC with the objective of strengthening its presence in market.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.



Top News Today
MTNL investing Rs 190 crore to upgrade services
(21-May-2018)

MTNL investing Rs 190 crore to upgrade servicesMahanagar Telephone Nigam (MTNL) is investing Rs 190 crore to upgrade its services and may also get 4G spectrum, which will support the company to stay relevant in the highly competitive market.MTNL was......click on news to read complete article.

RIL gets environmental clearance for expansion project in Maharashtra
(21-May-2018)

RIL gets environmental clearance for expansion project in MaharashtraReliance Industries (RIL) has received environment clearance for the expansion and optimisation of its petrochemical complex at Nagothane in Raigad district of Maharashtra at an estimated cost of Rs 2,338......click on news to read complete article.

L&T's arm bags two orders from HURL
(21-May-2018)

L&TLarsen & Toubro's (L&T's) wholly owned subsidiary -- L&T Hydrocarbon Engineering (LTHE) in consortium with TechnipFMC has won two significant orders from Hindustan Urvarak and Rasayan......click on news to read complete article.

International Stock News
Asian markets trade firm as US-China trade tensions ease
(21-May-2018)

Asian markets trade firm as US-China trade tensions easeAsian markets are trading mostly in green in early deals on Monday, after fears of a trade war between the U.S. and China receded following weekend developments. U.S. Treasury Secretary Steve Mnuchin said......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.